Marty retired (at the end of 2015) as the Chief Scientific Officer and Director of Promega Corporation, in Madison, WI. He joined Promega after retiring in 2001 as Senior Vice President of Anti-Infectives Drug Discovery and Development at GlaxoSmithKline. He spent 20 years in the SmithKline R&D Organization, including service as Senior Vice President in R&D. Marty served on the Board of Directors for the Medical College of Wisconsin Research Foundation; Anacor Pharmaceuticals; and Cubist Pharmaceuticals. He continues to serve as a Director of DNASTAR and Scarab Genomics in WI. He also served as a member of the Advisory Council for the National Institutes of Allergy & Infectious Diseases and on the Council for the Office of the Director at the National Institutes of Health. Before joining SmithKline Pharmaceutical R&D, Marty spent 10 years at the National Institutes of Health and was a Section Chief in the National Cancer Institute. He has served as a member of the Science Advisory Board of the FDA, and on the National Medal of Technology Evaluation Committee. He has been awarded the Arthur S. Fleming Award, the Panlabs Award in Microbiology, and the Distinguished Alumni Award from Purdue University.
Marty has been a member of the Pappas Ventures Scientific Advisory Board since 2007.
Purdue University (PhD)
© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.